left space About Us Product Candidates Newsroom Investor Information Business Development

IDDS logo
c Investors Information
left space Overview   Governance   SEC Filings   News Releases   Stock Quote   FAQs   Events   Email Notification   Investor Kit    Snapshot

pixel shim

SEC Filings

     
 
Filing Date Sorted Descending Filing Description Size
7/2/2009 4 clegg, jackie m 19.2 KB
7/2/2009 4 watson, douglas g 19.2 KB
5/7/2009 10-Q quarterly report 714.7 KB
5/7/2009 8-K current report 57.4 KB
5/5/2009 4 nebgen, georg 19.2 KB
5/5/2009 4 kiernan, peter d. iii 19.2 KB
5/5/2009 4 clegg, jackie m 19.2 KB
5/5/2009 4 watson, douglas g 19.2 KB
5/5/2009 4 carr, daniel b 19.3 KB
5/5/2009 4 driscoll, martin j 19.4 KB
5/5/2009 4 tulipano, stephen j 20.5 KB
5/5/2009 4 flanzraich, neil 19.2 KB
5/5/2009 8-K current report 21.7 KB
4/30/2009 DEF 14A definitive proxy statement 393.9 KB
4/14/2009 8-K current report 20.6 KB
3/12/2009 10-K annual report 1.1 MB
3/12/2009 8-K current report 68.3 KB
3/3/2009 8-K current report 22.5 KB
2/27/2009 4 tulipano, stephen j 19.4 KB
2/27/2009 4 carr, daniel b 19.8 KB
Showing 1-20 of 286 filings Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  See Next 20
 

 

CONTACT US   JOIN US   SITE MAP
© 2009 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.